Growth Metrics

Biogen (BIIB) Minority Interest (2016 - 2023)

Biogen has reported Minority Interest over the past 15 years, most recently at -$4.1 million for Q3 2023.

  • Quarterly results put Minority Interest at -$4.1 million for Q3 2023, up 52.87% from a year ago — trailing twelve months through Sep 2023 was -$4.1 million (up 52.87% YoY), and the annual figure for FY2022 was -$9.5 million, down 114.96%.
  • Minority Interest for Q3 2023 was -$4.1 million at Biogen, up from -$6.4 million in the prior quarter.
  • Over the last five years, Minority Interest for BIIB hit a ceiling of $462.9 million in Q2 2021 and a floor of -$21.6 million in Q1 2022.
  • Median Minority Interest over the past 5 years was -$8.7 million (2022), compared with a mean of $42.8 million.
  • Biggest five-year swings in Minority Interest: plummeted 375.61% in 2020 and later soared 3327.14% in 2021.
  • Biogen's Minority Interest stood at -$4.1 million in 2019, then plummeted by 246.34% to -$14.2 million in 2020, then surged by 547.18% to $63.5 million in 2021, then crashed by 114.96% to -$9.5 million in 2022, then soared by 56.84% to -$4.1 million in 2023.
  • The last three reported values for Minority Interest were -$4.1 million (Q3 2023), -$6.4 million (Q2 2023), and -$9.6 million (Q1 2023) per Business Quant data.